Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Hard Copy Ovarian Cancer Therapeutics - Global Strategic Business Report Global Industry Analysts, Inc., Feb 2006, Pages: 248   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   This report analyzes the worldwide markets for Ovarian Cancer Therapeutics in Millions of US$. The major product segments analyzed are Localized Ovarian Cancer Therapeutics, Metastatic Ovarian Cancer Therapeutics, and Refractory Ovarian Cancer Therapeutics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 42 companies including many key and niche players worldwide such as Alza Corporation, Amgen, Inc., Bristol-Myers Squibb, Cell Therapeutics, Inc., Genentech Inc., GlaxoSmithkline, Immunogen, Inc., Ivax, OSI Pharmaceuticals, and Raven Biotechnologies, Inc. Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on 'Enquire before buying' Customers who bought this item also bought Breast Cancer Therapeutics - Global Strategic Business Report Genetic Testing - Global Strategic Business Report Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report Monoclonal Antibody Based Products - Global Strategic Business Report Gene Amplification Technologies - Global Strategic Business Report Antidepressants - Global Strategic Business Report Gene Therapy - Global Strategic Business Report Angiogenesis Inhibitors and Stimulators - Global Strategic Business Report System-On-A-Chip (SOC) - Global Strategic Business Report Automotive Fuel Injectors - Global Strategic Business Report Airborne Surveillance and Reconnaissance Systems - Global Strategic Business Report Nanobiotechnology - Global Strategic Business Report

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster